Supramolecular nanotherapeutics based on cucurbiturils

J Nanobiotechnology. 2024 Dec 23;22(1):790. doi: 10.1186/s12951-024-03024-z.

Abstract

Polymeric biomaterials have important applications in aiding clinical disease treatment, including drug delivery, bioimaging, and tissue engineering. Currently, conventional tumor chemotherapy faces obstacles such as poor solubility/stability, inability to target, and uncontrolled drug release in clinical trials, for which the emergence of supramolecular material therapeutics combining non-covalent interactions with conventional therapies is a very promising candidate. Due to their molecular recognition abilities with a range of biomolecules, cucurbit[n]uril (CB[n]), a type of macrocyclic receptors with robust backbones, hydrophobic cavities, and carbonyl-binding channels, have garnered a lot of attention. Therefore, this paper reviews recent advances in CB[n] material-based supramolecular therapeutics for clinical treatments, including targeted delivery applications and related imaging and sensing systems. This study also covers the distinctive benefits of CB materials for biological applications, as well as the trends and prospects of this interdisciplinary subject, based on numerous state-of-the-art research findings.

Keywords: Cucurbiturils; Host–guest chemistry; Targeted therapy.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Bridged-Ring Compounds* / chemistry
  • Bridged-Ring Compounds* / pharmacology
  • Bridged-Ring Compounds* / therapeutic use
  • Drug Carriers / chemistry
  • Drug Delivery Systems / methods
  • Humans
  • Imidazolidines* / chemistry
  • Imidazolidines* / pharmacology
  • Imidazolidines* / therapeutic use
  • Macrocyclic Compounds* / chemistry
  • Macrocyclic Compounds* / pharmacology
  • Macrocyclic Compounds* / therapeutic use
  • Nanomedicine / methods
  • Nanoparticles / chemistry
  • Neoplasms / drug therapy

Substances

  • Antineoplastic Agents
  • Bridged-Ring Compounds
  • cucurbit(n)uril
  • Drug Carriers
  • Imidazolidines
  • Macrocyclic Compounds